Type a ticker — we pressure-test it against live facts, filings, and sentiment.
Thermo Fisher Scientific Inc. — Healthcare · Diagnostics & Research carries a Plainview business-quality score of 8.1/10, built deterministically from SEC filings and Yahoo Finance: revenue, margins, cash, valuation, and a confluence buy zone. The live X-Ray loads below.
On the fundamentals, Thermo Fisher Scientific Inc. shows trailing revenue of $46.34B, a 41.0% gross margin, net debt of $15.40B, EPS of 17.80, valued at about 4.9x times sales. X-Ray measures business quality only — momentum and entry timing live in Decide and Opportunity Cost.
Compare: TMO vs UNH · TMO vs JNJ · TMO vs LLY | Also: UNH, JNJ, LLY, PFE, MRK, ABBV